Celon Pharma SA — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Celon Pharma SA appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

6 shown

Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid ArthritisNCT05374785 · lead sponsor · 2022-05-01

Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 DiabetesNCT05248776 · lead sponsor · 2022-01-21

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced DyskinesiaNCT05297201 · lead sponsor · 2021-11-02

Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With SchizophreniaNCT05278156 · lead sponsor · 2021-05-19

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesNCT04149691 · lead sponsor · 2019-07-19

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant DepressionNCT03965858 · lead sponsor · 2019-02-25

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.